Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Leveraging biology and technology to improve symptoms and quality of life of cancer survivors

Biological basis of exercise and physical activity on quality of life in cancer survivors

Date

12 Sep 2022

Session

Leveraging biology and technology to improve symptoms and quality of life of cancer survivors

Topics

Supportive Care and Symptom Management;  Survivorship;  Surgical Oncology

Tumour Site

Breast Cancer;  Colon and Rectal Cancer

Presenters

Justin Jeon

Authors

J. Jeon

Author affiliations

  • Yonsei University, 03722 - Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction and scientific background

Presenter: Ines Vaz Luis

Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Justin Jeon

Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.